Stem Cell Authority, Ltd. (SCAL)

Market Cap	2.44M
Revenue (ttm)	3.33M +11,044.2%
Net Income	1.83M
EPS	0.01
Shares Out	12.18B
PE Ratio	0.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,100
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.000001 - 0.0150
Beta	3.01
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Stem Cell Authority

Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton’s jelly inside the umbilical cord of a newborn child. The company’s technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Carlzo Cardwell
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: SCAL

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 7, 2026

Data Sources Report a data error